| |
|
MASH | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 6. | Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adults |
| |
Geroscience. 2024 Nov 28. doi: 10.1007/s11357-024-01435-2. Online ahead of print.
Daniel Clayton-Chubb 1 2 3 4, Stuart K Roberts 5 6, Ammar Majeed 5 6, Robyn L Woods 7, Andrew M Tonkin 7, Mark R Nelson 7 8, Andrew T Chan 9 10 11, Joanne Ryan 7, Cammie Tran 7, Alexander Hodge 12 13 14, John S Lubel 5 6 15, Hans G Schneider 7 16, Amy Brodtmann 13 17, Sharyn M Fitzgerald 7, Suzanne G Orchard 7, John J McNeil 7, William W Kemp 5 6
|
|
| |
| 7. | Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease |
| |
J Hepatol. 2024 Nov 26:S0168-8278(24)02728-4.doi: 10.1016/j.jhep.2024.11.028. Online ahead of print.
Juan Pablo Arab 1, Luis Antonio Díaz 2, Jürgen Rehm 3, Gene Im 4, Marco Arrese 5, Patrick S Kamath 6, Michael R Lucey 7, Jessica Mellinger 8, Maja Thiele 9, Mark Thursz 10, Ramon Bataller 11, Robyn Burton 12, Shilpa Chokshi 13, Sven M Francque 14, Aleksander Krag 9, Carolin Lackner 15, Brian P Lee 16, Suthat Liangpunsakul 17, Craig MacClain 18, Pranoti Mandrekar 19, Mack C Mitchell 20, Marsha Y Morgan 21, Timothy R Morgan 22, Elisa Pose 11, Vijay H Shah 6, Debbie Shawcross 23, Nick Sheron 24, Ashwani K Singal 18, Horia Stefanescu 25, Norah Terrault 16, Eric Trépo 26, Christophe Moreno 26, Alexandre Louvet 27, Philippe Mathurin 28
|
|
| |
| 8. | Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15-39, 1990-2021 |
| |
Clin Nutr. 2024 Nov 14;43(12):391-404. doi: 10.1016/j.clnu.2024.11.016. Online ahead of print.
Xiao-Dong Zhou 1, Qin-Fen Chen 2, Giovanni Targher 3, Christopher D Byrne 4, Christos S Mantzoros 5, Huijie Zhang 6, Amedeo Lonardo 7, Gregory Y H Lip 8, Gilda Porta 9, Anoop Misra 10, Andrew Gerard Robertson 11, Fei Luo 12, Anna Alisi 13, Wah Yang 14, Mortada El-Shabrawi 15, Hazem Al Momani 16, Virend K Somers 17, Christos S Katsouras 18, Nahum Méndez-Sánchez 19, Sander Lefere 20, Olivia Szepietowski 21, Ki-Chul Sung 22, Nicholas Beng Hui Ng 23, Luca Valenti 24, Way Seah Lee 25, Alice Pik-Shan Kong 26, Mehmet Celal Kizilkaya 27, Ponsiano Ocama 28, Arshad Ali 29, Octavio Viveiros 30, John D Ryan 31, Carlos Jesus Toro-Huamanchumo 32, Nilanka Perera 33, Karim Ataya 34, Kenneth Yuh Yen Kok 35, Jordi Gracia-Sancho 36, Ala I Sharara 37, Arun Prasad 38, Rodolfo J Oviedo 39, Oral Ospanov 40, Elena Ruiz-Úcar 41, Khalid Alswat 42, Syed Imran Abbas 43, Tamer N Abdelbaki 44, Yu Jun Wong 45, Yasser Fouad 46, Michael D Shapiro 47, Flora Bacopoulou 48, Silvia Sookoian 49, Mohit Kehar 50, Wah-Kheong Chan 51, Sombat Treeprasertsuk 52, Leon Adams 53, Serap Turan 54, Mauricio Zuluaga 55, Carlos Jose Pirola 56, Omar Thaher 57, Gabriel Alejandro Molina 58, Nozim Adxamovich Jumaev 59, Said A Al-Busafi 60, Christopher K Opio 61, Michelle Ching Lim-Loo 62, Cosmas Rinaldi Adithya Lesmana 63, Lubna Kamani 64, Ming-Hua Zheng 65
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 24. | Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial |
| |
Lancet Gastroenterol Hepatol. 2024 Oct 10:S2468-1253(24)00246-2.doi: 10.1016/S2468-1253(24)00246-2. Online ahead of print.
Rohit Loomba 1, Pierre Bedossa 2, Katharine Grimmer 3, George Kemble 3, Eduardo Bruno Martins 3, William McCulloch 3, Marie O'Farrell 3, Wen-Wei Tsai 3, Jose Cobiella 4, Eric Lawitz 5, Madhavi Rudraraju 6, Stephen A Harrison 6
|
|
| |
|
|
| |
| 26. | acFibroMASH index for the diagnosis of fibrotic MASH and prediction of liver-related events: An international multicenter study |
| |
ClinGastroenterolHepatol. 2024Oct1:S15423565(24)008632.doi:10.1016/j.cgh.2024.07.045. Online ahead of print.
Gong Feng 1, Ferenc E Mózes 2, Dong Ji 3, Sombat Treeprasertsuk 4, Takeshi Okanoue 5, Toshihide Shima 5, Huiqing Liang 6, Emmanuel Tsochatzis 7, Jinjun Chen 8, Jorn M Schattenberg 9, Christian Labenz 9, Sanjiv Mahadeva 10, Wah Kheong Chan 10, Xiaoling Chi 11, Adele Delamarre 12, Victor de Lédinghen 12, Salvatore Petta 13, Elisabetta Bugianesi 14, Hannes Hagström 15, Jerome Boursier 16, Jose Luis Calleja 17, George Boon-Bee Goh 18, Rocio Gallego-Durán 19, Arun J Sanyal 20, Jian-Gao Fan 21, Laurent Castéra 22, Michelle Lai 23, Stephen A Harrison 24, Manuel Romero-Gomez 19, Seung Up Kim 25, Yongfen Zhu 26, Geraldine Ooi 27, Junping Shi 28, Masato Yoneda 29, Atsushi Nakajima 29, Jing Zhang 30, Monica Lupsor-Platon 31, Bihui Zhong 32, Jeremy F L Cobbold 33, Chun-Yan Ye 34, Peter J Eddowes 35, Philip Newsome 36, Jie Li 37, Jacob George 38, Fangping He 39, Myeong Jun Song 40, Hong Tang 41, Yuchen Fan 42, Jidong Jia 43, Liang Xu 44, Su Lin 45, Yiling Li 46, Zhonghua Lu 47, Yuemin Nan 48, Junqi Niu 49, Xuebing Yan 50, Yongjian Zhou 51, Chenghai Liu 52, Hong Deng 53, Qing Ye 54, Qing-Lei Zeng 55, Lei Li 56, Jing Wang 57, Song Yang 58, Huapeng Lin 59, Hye Won Lee 25, Terry Cheuk-Fung Yip 59, Céline Fournier-Poizat 60, Grace Lai-Hung Wong 59, Grazia Pennisi 13, Angelo Armandi
|
| |
|
|
| |
|
|
| |
| 30. | PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease |
| |
Hepatology. 2024 Nov 1;80(5):1212-1226. doi: 10.1097/HEP.0000000000000896.Epub 2024 Apr 23.
Naga Chalasani 1, Eduardo Vilar-Gomez 1, Rohit Loomba 2, Katherine P Yates 3, Anna Mae Diehl 4, Brent A Neuschwander-Tetri 5, Srinivasan Dasarathy 6, Kris V Kowdley 7, Norah Terrault 8, Laura A Wilson 3, James Tonascia 9, Arun J Sanyal 10
|
|
| |
| 31. | Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis |
| |
Nat Med. 2024 Nov 4. doi: 10.1038/s41591-024-03301-2. Online ahead of print.
Hanna Pulaski # 1, Stephen A Harrison # 2, Shraddha S Mehta 1 3, Arun J Sanyal 4, Marlena C Vitali 1 5, Laryssa C Manigat 1, Hypatia Hou 1, Susan P Madasu Christudoss 1 6, Sara M Hoffman 1 7, Adam Stanford-Moore 1, Robert Egger 1, Jonathan Glickman 1 8, Murray Resnick 1 9, Neel Patel 1, Cristin E Taylor 1, Robert P Myers 10, Chuhan Chung 11, Scott D Patterson 12, Anne-Sophie Sejling 13, Anne Minnich 14, Vipul Baxi 14, G Mani Subramaniam 10, Quentin M Anstee 15, Rohit Loomba 16, Vlad Ratziu 17, Michael C Montalto 1 18, Nick P Anderson 1, Andrew H Beck 1, Katy E Wack 19
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 35. | Obesity and risk for liver disease: a two-sample Mendelian randomisation study |
| |
Br J Nutr. 2024 Nov 6:1-8. doi: 10.1017/S000711452400237X. Online ahead of print.
Wen An # 1, Jing Luo # 2, Zhe Yu 2, Mengqi Li 1, Herui Wei 1, Aqian Song 1, Yuanpeng Mao 2, Hao Bian 1, Lingling He 1, Fan Xiao 3 4 5 6, Hongshan Wei 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 42. | Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial |
| |
Lancet Gastroenterol Hepatol. 2024 Oct 10:S2468-1253(24)00246-2.doi: 10.1016/S2468-1253(24)00246-2. Online ahead of print.
Rohit Loomba 1, Pierre Bedossa 2, Katharine Grimmer 3, George Kemble 3, Eduardo Bruno Martins 3, William McCulloch 3, Marie O'Farrell 3, Wen-Wei Tsai 3, Jose Cobiella 4, Eric Lawitz 5, Madhavi Rudraraju 6, Stephen A Harrison 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 48. | HAF prevents hepatocyte apoptosis and progression to MASH and hepatocellular carcinoma through transcriptional regulation of the NF-?B pathway |
| |
Hepatology. 2024 Sep 10. doi: 10.1097/HEP.0000000000001070. Online ahead of print.
Karen Acuña-Pilarte 1, Ethan C Reichert 1, Yangsook Song Green 1, Lily M-T Halberg 1, Martin Golkowski 1, Kathleen M Maguire, Patrice N Mimche 1, Severin Donald Kamdem 1, Po-An Hu 1, Jillian Wright 1, Gregory S Ducker 1, Warren P Voth 1 2, Ryan M O'Connell 1 2, Sydney A McFarland 1, Erika Said Abu Egal 1, Amandine Chaix 1, Scott A Summers 1, Jordan W Reelitz 1, J Alan Maschek 1, James E Cox 1, Kimberley J Evason 2, Mei Yee Koh 1
|
|
| |
| 49. | acFibroMASH index for the diagnosis of fibrotic MASH and prediction of liver-related events: An international multicenter study |
| |
ClinGastroenterolHepatol. 2024Oct1:S15423565(24)008632.doi:10.1016/j.cgh.2024.07.045. Online ahead of print.
Gong Feng 1, Ferenc E Mózes 2, Dong Ji 3, Sombat Treeprasertsuk 4, Takeshi Okanoue 5, Toshihide Shima 5, Huiqing Liang 6, Emmanuel Tsochatzis 7, Jinjun Chen 8, Jorn M Schattenberg 9, Christian Labenz 9, Sanjiv Mahadeva 10, Wah Kheong Chan 10, Xiaoling Chi 11, Adele Delamarre 12, Victor de Lédinghen 12, Salvatore Petta 13, Elisabetta Bugianesi 14, Hannes Hagström 15, Jerome Boursier 16, Jose Luis Calleja 17, George Boon-Bee Goh 18, Rocio Gallego-Durán 19, Arun J Sanyal 20, Jian-Gao Fan 21, Laurent Castéra 22, Michelle Lai 23, Stephen A Harrison 24, Manuel Romero-Gomez 19, Seung Up Kim 25, Yongfen Zhu 26, Geraldine Ooi 27, Junping Shi 28, Masato Yoneda 29, Atsushi Nakajima 29, Jing Zhang 30, Monica Lupsor-Platon 31, Bihui Zhong 32, Jeremy F L Cobbold 33, Chun-Yan Ye 34, Peter J Eddowes 35, Philip Newsome 36, Jie Li 37, Jacob George 38, Fangping He 39, Myeong Jun Song 40, Hong Tang 41, Yuchen Fan 42, Jidong Jia 43, Liang Xu 44, Su Lin 45, Yiling Li 46, Zhonghua Lu 47, Yuemin Nan 48, Junqi Niu 49, Xuebing Yan 50, Yongjian Zhou 51, Chenghai Liu 52, Hong Deng 53, Qing Ye 54, Qing-Lei Zeng 55, Lei Li 56, Jing Wang 57, Song Yang 58, Huapeng Lin 59, Hye Won Lee 25, Terry Cheuk-Fung Yip 59, Céline Fournier-Poizat 60, Grace Lai-Hung Wong 59, Grazia Pennisi 13, Angelo Armandi
|
| |
| 51. | Liver transplant recipients have worse metabolic body phenotype compared with matched non-transplant controls |
| |
JGH Open. 2024 Sep 24;8(9):e70024. doi: 10.1002/jgh3.70024. eCollection 2024 Sep.
Chandra Bhati 1, Danielle Kirkman 2, Mikael F Forsgren 3 4, Hiba Kamal 5 6, Hiba Khan 7, Sherry Boyett 5 6, Olof Dahlqvist Leinhard 3 4, Jennifer Linge 3, Vaishali Patel 5 7, Samarth Patel 8, Susan Wolver 7, Mohammad S Siddiqui 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 63. | Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis |
| |
J Pediatr Gastroenterol Nutr. 2024 Sep 16. doi: 10.1002/jpn3.12346. Online ahead of print.
Ajay K Jain 1, Stefanie A Busgang 2, Chris Gennings 2, Katherine P Yates 3, Jeffrey B Schwimmer 4, Philip Rosenthal 5, Karen F Murray 6, Jean P Molleston 7, Ann Scheimann 8, Stavra A Xanthakos 9, Cynthia A Behling 10 11, Danielle Carpenter 12, Mark Fishbein 13, Brent A Neuschwander-Tetri 14, James Tonasia 3, Miriam B Vos 15
|
|
| |
| 64. | Decreases in cT1 and liver fat content reflect treatment-induced histological improvements in MASH |
| |
J Hepatol. 2024 Sep 19:S0168-8278(24)02559-5. doi: 10.1016/j.jhep.2024.08.031.Online ahead of print.
Naim Alkhouri 1, Cayden Beyer 2, Elizabeth Shumbayawonda 2, Anneli Andersson 2, Kitty Yale 3, Timothy Rolph 3, Raymond T Chung 4, Raj Vuppalanchi 5, Kenneth Cusi 6, Rohit Loomba 7, Michele Pansini 8, Andrea Dennis 9
|
|
| |
| 65. | TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASH |
| |
Hepatology. 2024 Sep 18. doi: 10.1097/HEP.0000000000001098. Online ahead of print.
Gavin Fredrickson 1, Kira Florczak 1, Fanta Barrow 1, Shamsed Mahmud 2 3, Katrina Dietsche 1, Haiguang Wang 1, Preethy Parthiban 1, Andrew Hakeem 1, Rawan Almutlaq 1, Oyedele Adeyi 4, Adam Herman 5, Alessandro Bartolomucci 1, Christopher Staley 5, Xiao Dong 2 3, Cyrus Jahansouz 5, Jesse W Williams 1 6, Douglas G Mashek 3 7, Sayeed Ikramuddin 5, Xavier S Revelo 1 3 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 69. | DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases |
| |
Metabolism. 2024 Oct:159:155931. doi: 10.1016/j.metabol.2024.155931.Epub 2024 Jun 7.
Yehuda Handelsman 1, John E Anderson 2, George L Bakris 3, Christie M Ballantyne 4, Deepak L Bhatt 5, Zachary T Bloomgarden 6, Biykem Bozkurt 7, Matthew J Budoff 8, Javed Butler 9, David Z I Cherney 10, Ralph A DeFronzo 11, Stefano Del Prato 12, Robert H Eckel 13, Gerasimos Filippatos 14, Gregg C Fonarow 8, Vivian A Fonseca 15, W Timothy Garvey 16, Francesco Giorgino 17, Peter J Grant 18, Jennifer B Green 19, Stephen J Greene 20, Per-Henrik Groop 21, George Grunberger 22, Ania M Jastreboff 23, Paul S Jellinger 24, Kamlesh Khunti 25, Samuel Klein 26, Mikhail N Kosiborod 27, Pamela Kushner 28, Lawrence A Leiter 29, Norman E Lepor 8, Christos S Mantzoros 30, Chantal Mathieu 31, Christian W Mende 32, Erin D Michos 33, Javier Morales 34, Jorge Plutzky 35, Richard E Pratley 36, Kausik K Ray 37, Peter Rossing 38, Naveed Sattar 39, Peter E H Schwarz 40, Eberhard Standl 41, P Gabriel Steg 42, Lale Tokgözoglu 43, Jaakko Tuomilehto 44, Guillermo E Umpierrez 45, Paul Valensi 46, Matthew R Weir 47, John Wilding 48, Eugene E Wright Jr 49
|
|
| |
|
|
| |
|
|
| |
| 72. | GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease |
| |
JAMA Intern Med. 2024 Sep 16:e244661. doi: 10.1001/jamainternmed.2024.4661.Online ahead of print.
Fasiha Kanwal 1 2 3 4, Jennifer R Kramer 2 3, Liang Li 5, Yu-Xiao Yang 6 7, Yumei Cao 2 3, Xian Yu 2 3, Ronald Samuel 1 3, Basim Ali 1, Roxanne Desiderio 1 3, George Cholankeril 1, Mandeep Bajaj 8, Hashem B El-Serag 1 3 4, Steven M Asch 9 10
|
|
| |
| 73. | Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms |
| |
Hepatol. 2024 Oct;81(4):590-599. doi: 10.1016/j.jhep.2024.05.021. Epub 2024 May 23.
Margarita Papatheodoridi 1, Victor De Ledinghen 2, Monica Lupsor-Platon 3, Fabrizio Bronte 4, Jerome Boursier 5, Omar Elshaarawy 6, Fabio Marra 7, Maja Thiele 8, Georgios Markakis 9, Audrey Payance 10, Edgar Brodkin 11, Laurent Castera 12, George Papatheodoridis 9, Aleksander Krag 8, Umberto Arena 7, Sebastian Mueller 13, Paul Cales 5, Vincenza Calvaruso 4, Adele Delamarre 2, Massimo Pinzani 11, Emmanuel A Tsochatzis 14
|
|
| |
| 74. | Longitudinal Links between Changes in Body Composition and Liver Disease Severity in Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Liver Disease |
| |
J Pediatr. 2024 Sep 13:114301. doi: 10.1016/j.jpeds.2024.114301. Online ahead of print.
Alexandria Speakman 1, Kathryn Hitchcock 2, Emily Romantic 2, Venancio Quiambao 2, Abigail Lepolt 2, Sanita Ley 3, Ana Catalina Arce-Clachar 1, Kristin Bramlage 4, Lin Fei 5, Qin Sun 5, Stavra Xanthakos 1, Marialena Mouzaki 6
|
|
| |
|
|
| |
| 76. | Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD |
| |
J Hepatol. 2024 Oct;81(4):600-608. doi: 10.1016/j.jhep.2024.05.008. Epub 2024 May 16.
Samer Gawrieh 1, Eduardo Vilar-Gomez 1, Laura A Wilson 2, Francis Pike 3, David E Kleiner 4, Brent A Neuschwander-Tetri 5, Anna Mae Diehl 6, Srinivasan Dasarathy 7, Kris V Kowdley 8, Bilal Hameed 9, James Tonascia 2, Rohit Loomba 10, Arun J Sanyal 11, Naga Chalasani 12; NASH Clinical Research Network
|
|
| |
|
|
| |
| 78. | Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants |
| |
Neurovirol. 2024 Aug 12. doi: 10.1007/s13365-024-01225-8. Online ahead of print.
Shanna L Burke 1, Adrienne Grudzien 2 3, Tan Li 4, Stephanie Garcia 4, Sabrina Sales Martinez 5, Emily Jurich 2, Daniel R Jimenez 2, Jacqueline Hernández 5, Qingyun Liu 5, Tahirah A Tyrell 6, Adriana L Campa 5, Anglique Johnson 5, Zoran Bursac 4, Marianna K Baum 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 82. | Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD |
| |
Diabetes Res Clin Pract. 2024 Aug 13:111820. doi: 10.1016/j.diabres.2024.111820.Online ahead of print.
Santo Colosimo 1, Hamish Miller 2, Dimitrios A Koutoukidis 3, Thomas Marjot 4, Garry D Tan 1, David J Harman 5, Guruprasad P Aithal 6, Pinelopi Manousou 7, Roberta Forlano 7, Richard Parker 8, David A Sheridan 9, Philip N Newsome 10, William Alazawi 11, Jeremy F Cobbold 12, Jeremy W Tomlinson 13
|
|
| |
|
|
| |
|
|
| |
| 85. | Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction-associated steatotic liver disease but is not altered by 6 weeks of exercise training |
| |
Diabetes Obes Metab. 2024 Sep;26(9):4030-4042.doi: 10.1111/dom.15755. Epub 2024 Jul 8.
Scott A Willis 1 2, Sundus Malaikah 1 2 3, Stephen J Bawden 4 5, Aron P Sherry 1 2 6, Jack A Sargeant 2 7, Nicole A Coull 2 8, Christopher R Bradley 4 5, Alex Rowlands 2 8, Iyad Naim 4 5, Gaël Ennequin 9, Thomas Yates 2 8, Ghazala Waheed 2 8, Penny Gowland 4 5, David J Stensel 1 2 10, David R Webb 2 8, Melanie J Davies 2 8, Guruprasad P Aithal 5 11, James A King 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 89. | Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease |
| |
Radiology. 2024 Sep;312(3):e233094. doi: 10.1148/radiol.233094.
Theodore T Pierce # 1, Arinc Ozturk # 1, Sarah P Sherlock 1, Guilherme Moura Cunha 1, Xiaohong Wang 1, Qian Li 1, David Hunt 1, Michael S Middleton 1, Marian Martin 1, Kathleen E Corey 1, Hannah Edenbaum 1, Sudha S Shankar 1, Helen Heymann 1, Tania N Kamphaus 1, Roberto A Calle 1, Yesenia Covarrubias 1, Rohit Loomba 1, Nancy A Obuchowski 1, Arun J Sanyal 1, Claude B Sirlin 1, Kathryn J Fowler # 1, Anthony E Samir # 1
|
|
| |
|
|
| |
|
|
| |
| 92. | Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies |
| |
Liver Int. 2024 Aug 19. doi: 10.1111/liv.16075. Online ahead of print.
Grazia Pennisi 1, Giuseppe Infantino 1, Ciro Celsa 1, Gabriele Di Maria 1, Marco Enea 2, Marco Vaccaro 2, Roberto Cannella 3, Carlo Ciccioli 1, Claudia La Mantia 1, Alessandro Mantovani 4, Francesco Mercurio 1, Herbert Tilg 5, Giovanni Targher 6 7, Vito Di Marco 1, Calogero Cammà 1, Salvatore Petta 1
|
|
| |
|
|
| |
|
|
| |
| 95. | MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls |
| |
Aliment Pharmacol Ther. 2024 Sep 5. doi: 10.1111/apt.18236. Online ahead of print.
Daniela S Allende 1, Oscar Cummings 2, Alice L Sternberg 3, Cynthia A Behling 4, Danielle Carpenter 5, Ryan M Gill 6, Cynthia D Guy 7, Matthew M Yeh 8, Samer Gawrieh 9, Richard K Sterling 10, Susanna Naggie 11, Rohit Loomba 12, Jennifer C Price 6, Mary McLaughlin 13, Colleen Hadigan 13, Holly Crandall 2, Patricia Belt 3, Laura Wilson 3, Naga P Chalasani 9, David E Kleiner 14; HIV NASH and NASH Clinical Research Groups
|
|
| |
| 96. | Prognosis of Transplant-Ineligible Patients with Cirrhosis and Acute Kidney Injury Who Initiate Renal Replacement Therapy |
| |
Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08623-2. Online ahead of print.
Paige McLean Diaz 1, Danielle L Saly 2, Nora Horick 3, Romela Petrosyan 4, Zachary Gitto 5, Teresa Indriolo 6, Lucinda Li 6, Olivia Kahn-Boesel 7, John Donlan 7, Blair Robinson 8, Lindsay Dow 8, Annie Liu 2, Areej El-Jawahri 9, Xavier Vela Parada 10, Sara Combs 11, Joao Teixeira 12, Raymond Chung 6, Andrew S Allegretti 2, Nneka N Ufere 13
|
|
| |
|
|
| |
|
|
| |
| 99. | Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility |
| |
J Gastroenterol Hepatol. 2024 Aug 27. doi: 10.1111/jgh.16727. Online ahead of print.
Connor Henry-Blake 1, Vinay Balachandrakumar 1, Mohamed Kassab 1, Joshua Devonport 1, Charmaine Matthews 1, James Fox 1, Elisabeth Baggus 1, Alexander Henney 2 3 4, Nicholas Stern 1, Daniel J Cuthbertson 2 3 4, Daniel Palmer 5, Philip J Johnson 5, David M Hughes 6, Theresa J Hydes 1 3 4, Timothy J S Cross 1 5
|
|
| |
| 100. | EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) |
| |
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031.Epub 2024 Jun 7.
European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu; European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO); European Association for the Study of the Liver (EASL)
Collaborators
- Frank Tacke, Paul Horn, Vincent Wai-Sun Wong, Vlad Ratziu, Elisabetta Bugianesi, Sven Francque, Shira Zelber-Sagi, Luca Valenti, Michael Roden, Fritz Schick, Hannele Yki-Järvinen, Amalia Gastaldelli, Roberto Vettor, Gema Frühbeck, Dror Dicker
|
|
| |
|
|
| |
|
|
| |
| 103. | Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study |
| |
Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001015. Online ahead of print.
Daniel Q Huang 1 2 3, Laura A Wilson 4, Cynthia Behling 5, Maral Amangurbanova 1, David E Kleiner 6, Kris V Kowdley 7, Srinivasan Dasarathy 8, Norah A Terrault 9, Anna Mae Diehl 10, Naga Chalasani 11, Brent A Neuschwander-Tetri 12, Arun J Sanyal 13, James Tonascia 4, Rohit Loomba 1 14; NASH Clinical Research Network
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 112. | Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants |
| |
Neurovirol. 2024 Aug 12. doi: 10.1007/s13365-024-01225-8. Online ahead of print.
Shanna L Burke 1, Adrienne Grudzien 2 3, Tan Li 4, Stephanie Garcia 4, Sabrina Sales Martinez 5, Emily Jurich 2, Daniel R Jimenez 2, Jacqueline Hernández 5, Qingyun Liu 5, Tahirah A Tyrell 6, Adriana L Campa 5, Anglique Johnson 5, Zoran Bursac 4, Marianna K Baum 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 117. | Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis |
| |
N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943.Epub 2024 Jun 8.
Rohit Loomba 1, Mark L Hartman 1, Eric J Lawitz 1, Raj Vuppalanchi 1, Jérôme Boursier 1, Elisabetta Bugianesi 1, Masato Yoneda 1, Cynthia Behling 1, Oscar W Cummings 1, Yuanyuan Tang 1, Bram Brouwers 1, Deborah A Robins 1, Amir Nikooie 1, Mathijs C Bunck 1, Axel Haupt 1, Arun J Sanyal 1; SYNERGY-NASH Investigators
Collaborators
- SYNERGY-NASH Investigators:
Christophe De Block, Charlotte De Vloo, Hendrik Reynaert, Ann Mertens, Anja Geerts, Christophe Bureau, Lionel Wander, Vlad Ratziu, Jérôme Boursier, Victor De Ledinhgen, Cyrielle Caussy, Marie Lequoy, Armelle Poujol Robert, Eli Zuckerman, Ella Veitsman, Rifaat Safadi, Ziv Ben-Ari, Gadi Lalazar, Nimer Assy, Emanuela Orsi, Gaetano Serviddio, Elisabetta Bugianesi, Salvatore Petta, Palermo Palermo, Luca Miele, Frida Leonetti, Kazuo Notsumata, Yasuhiro Asahina, Yuji Ogawa, Yokohama Yoshiyuki Ueno, Shigetoshi Fujiyama, Toshihide Shima, Masato Yoneda, Hirokazu Takahashi, Saga Hiroshi Tobita, Hideki Hayashi, Takeshi Yokoo, Masahiro Kido, Masashi Yoneda, Ken Furuya, Saiyu Tanaka, Yoshito Itoh, Hideki Fujii, Alma Laura Ladron de Guevara, Jorge Rojas Serrano, Enrique Fernandez Castro, Eduardo Mendoza Fuerte, Marcin Ojrzanowski, Ewa Czernecka, Santiago Tofe Povedano, Luis de Teresa Parreño, Javier Garcia de Paso Mora, Manuel Romero Gomez, Javier Crespo Garcia, Jose Luis Calleja Panero, Agustin Albillos, Shalini Iyengar, Carol Pretswell, Madhu Gowda, Karen Faulkner, Kosh Agarwal, William Alazawi, Cyril Sieberhagen, Pinelopi Manousou, Stephen Ryder, Jeremy Cobbold, Matthew Armstrong, Daniel Forton, Seth Baum, Juan Pablo Frias, David Guzman, Stanley Hsia, Julio Rosenstock, Kathryn Jean Lucas, Andrew Talal, Ajay Chaudhuri, Susan Brian, Tira Chaicha-Brom, Anuj Bhargava, Gholamreza Bonabi, Mark Borchelt, Michele Reynolds, Sherif Naguib, Rizwana Mohseni, Hernan Salazar, Thomas Klein, Richard Glover, John Scott, Eva-Maria Heurich, Hesham Elgouhari, Syed Lateef, Zeid Kayali, Gary Reiss, Rohit Loomba, Brian Borg, Muhammad Sheikh, Raj Vuppalanchi, Howard Schwartz, Meagan Gray, Charles Landis, Ira Jacobson, Henry Levine, Meena Bansal, Amreen Dinani, Amon Asgharpour, Eric Lawitz, Samuel Sigal, Abdullah Mubarak, Mark Leibowitz, Randall Severance, Jewel White, William Jennings, Judith White, Robert Meyer, Robert Perry, Robert Jenders, Mark McKenzie, Obadias Marquez, Christopher Still, Ernesto Fuentes, Kevin Merkes, Laura Pearlman
|
|
| |
|
|
| |
| 119. | Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis |
| |
Hepatology. 2024 Jul 1;80(1):173-185. doi: 10.1097/HEP.0000000000000723.Epub 2023 Dec 19.
Vlad Ratziu 1, Sven Francque 2 3 4, Cynthia A Behling 5, Vanja Cejvanovic 6, Helena Cortez-Pinto 7, Janani S Iyer 8, Niels Krarup 6, Quang Le 8, Anne-Sophie Sejling 6, Dina Tiniakos 9 10, Stephen A Harrison 11
|
|
| |
|
|
| |
|
|
| |
| 122. | Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD |
| |
J Intern Med. 2024 Aug;296(2):177-186. doi: 10.1111/joim.13813. Epub 2024 Jul 3.
Hannes Hegmar 1 2, Thomas Wiggers 3, Patrik Nasr 4, Johan Vessby 5, Stergios Kechagias 4, Nils Nyhlin 6, Hanns-Ulrich Marschall 7, Åsa Danielsson Borssén 8, Rickard Strandberg 2, Morten Karsdal 3, Diana Julie Leeming 3, Mattias Ekstedt 4, Hannes Hagström 1 2
|
|
| |
| 123. | Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretation |
| |
Am J Hum Genet. 2024 Jul 15:S0002-9297(24)00218-0. doi: 10.1016/j.ajhg.2024.06.011.Online ahead of print.
Melissa A Gilbert 1, Ernest Keefer-Jacques 2, Tanaya Jadhav 2, Daniel Antfolk 3, Qianqian Ming 3, Nicolette Valente 2, Grace Tzun-Wen Shaw 2, Christopher J Sottolano 4, Grace Matwijec 2, Vincent C Luca 3, Kathleen M Loomes 5, Ramakrishnan Rajagopalan 4, Tristan J Hayeck 4, Nancy B Spinner 4
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 127. | Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis |
| |
N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943.Epub 2024 Jun 8.
Rohit Loomba 1, Mark L Hartman 1, Eric J Lawitz 1, Raj Vuppalanchi 1, Jérôme Boursier 1, Elisabetta Bugianesi 1, Masato Yoneda 1, Cynthia Behling 1, Oscar W Cummings 1, Yuanyuan Tang 1, Bram Brouwers 1, Deborah A Robins 1, Amir Nikooie 1, Mathijs C Bunck 1, Axel Haupt 1, Arun J Sanyal 1; SYNERGY-NASH Investigators
Collaborators
SYNERGY-NASH Investigators:
Christophe De Block, Charlotte De Vloo, Hendrik Reynaert, Ann Mertens, Anja Geerts, Christophe Bureau, Lionel Wander, Vlad Ratziu, Jérôme Boursier, Victor De Ledinhgen, Cyrielle Caussy, Marie Lequoy, Armelle Poujol Robert, Eli Zuckerman, Ella Veitsman, Rifaat Safadi, Ziv Ben-Ari, Gadi Lalazar, Nimer Assy, Emanuela Orsi, Gaetano Serviddio, Elisabetta Bugianesi, Salvatore Petta, Palermo Palermo, Luca Miele, Frida Leonetti, Kazuo Notsumata, Yasuhiro Asahina, Yuji Ogawa, Yokohama Yoshiyuki Ueno, Shigetoshi Fujiyama, Toshihide Shima, Masato Yoneda, Hirokazu Takahashi, Saga Hiroshi Tobita, Hideki Hayashi, Takeshi Yokoo, Masahiro Kido, Masashi Yoneda, Ken Furuya, Saiyu Tanaka, Yoshito Itoh, Hideki Fujii, Alma Laura Ladron de Guevara, Jorge Rojas Serrano, Enrique Fernandez Castro, Eduardo Mendoza Fuerte, Marcin Ojrzanowski, Ewa Czernecka, Santiago Tofe Povedano, Luis de Teresa Parreño, Javier Garcia de Paso Mora, Manuel Romero Gomez, Javier Crespo Garcia, Jose Luis Calleja Panero, Agustin Albillos, Shalini Iyengar, Carol Pretswell, Madhu Gowda, Karen Faulkner, Kosh Agarwal, William Alazawi, Cyril Sieberhagen, Pinelopi Manousou, Stephen Ryder, Jeremy Cobbold, Matthew Armstrong, Daniel Forton, Seth Baum, Juan Pablo Frias, David Guzman, Stanley Hsia, Julio Rosenstock, Kathryn Jean Lucas, Andrew Talal, Ajay Chaudhuri, Susan Brian, Tira Chaicha-Brom, Anuj Bhargava, Gholamreza Bonabi, Mark Borchelt, Michele Reynolds, Sherif Naguib, Rizwana Mohseni, Hernan Salazar, Thomas Klein, Richard Glover, John Scott, Eva-Maria Heurich, Hesham Elgouhari, Syed Lateef, Zeid Kayali, Gary Reiss, Rohit Loomba, Brian Borg, Muhammad Sheikh, Raj Vuppalanchi, Howard Schwartz, Meagan Gray, Charles Landis, Ira Jacobson, Henry Levine, Meena Bansal, Amreen Dinani, Amon Asgharpour, Eric Lawitz, Samuel Sigal, Abdullah Mubarak, Mark Leibowitz, Randall Severance, Jewel White, William Jennings, Judith White, Robert Meyer, Robert Perry, Robert Jenders, Mark McKenzie, Obadias Marquez, Christopher Still, Ernesto Fuentes, Kevin Merkes, Laura Pearlman
|
|
| |
|
|
| |
|
|
| |
| 130. | Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study |
| |
Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001015. Online ahead of print.
Daniel Q Huang 1 2 3, Laura A Wilson 4, Cynthia Behling 5, Maral Amangurbanova 1, David E Kleiner 6, Kris V Kowdley 7, Srinivasan Dasarathy 8, Norah A Terrault 9, Anna Mae Diehl 10, Naga Chalasani 11, Brent A Neuschwander-Tetri 12, Arun J Sanyal 13, James Tonascia 4, Rohit Loomba 1 14; NASH Clinical Research Network
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 143. | A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease |
| |
Hepatol Int. 2024 Jun 15. doi: 10.1007/s12072-024-10702-5. Online ahead of print.
Huai Zhang 1, Giovanni Targher 2, Christopher D Byrne 3, Seung Up Kim 4, Vincent Wai-Sun Wong 5, Luca Valenti 6 7, Myer Glickman 8, Jaime Ponce 9, Christos S Mantzoros 10, Javier Crespo 11, Henning Gronbaek 12, Wah Yang 13, Mohammed Eslam 14, Robert J Wong 15, Mariana Verdelho Machado 16, Ming-Lung Yu 17 18, Omar M Ghanem 19, Takeshi Okanoue 20, Jun-Feng Liu 21, Yong-Ho Lee 22, Xiao-Yuan Xu 23, Qiuwei Pan 24, Meili Sui 25, Amedeo Lonardo 26, Yusuf Yilmaz 27, Li-Yong Zhu 28, Christophe Moreno 29, Luca Miele 30, Monica Lupsor-Platon 31, Lei Zhao 32, Teresa LeAnn LaMasters 33, Robert G Gish 34, Huijie Zhang 35, Marius Nedelcu 36, Wah Kheong Chan 37, Ming-Feng Xia 38, Fernando Bril 39, Jun-Ping Shi 40, Christian Datz 41, Stefano Romeo 42 43 44, Jian Sun 45, Dan Liu 46, Silvia Sookoian 47 48 49, Yi-Min Mao 50, Nahum Méndez-Sánchez 51, Xiao-Yan Wang 52, Nikolaos T Pyrsopoulos 53, Jian-Gao Fan 54, Yasser Fouad 55, Dan-Qin Sun 56 57, Cosimo Giannini 58, Jin Chai 59, Ze-Feng Xia 60, Dae Won Jun 61, Guo-Jing Li 62, Sombat Treeprasertsuk 63, Ying-Xu Li |
|
| |
|
|
| |
|
|
| |
| 146. | Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis |
| |
Hepatology. 2024 Jul 1;80(1):173-185. doi: 10.1097/HEP.0000000000000723.Epub 2023 Dec 19.
Vlad Ratziu 1, Sven Francque 2 3 4, Cynthia A Behling 5, Vanja Cejvanovic 6, Helena Cortez-Pinto 7, Janani S Iyer 8, Niels Krarup 6, Quang Le 8, Anne-Sophie Sejling 6, Dina Tiniakos 9 10, Stephen A Harrison 11
|
|
| |
|
|
| |
|
|
| |
| 149. | The cost implications of Wilson disease among hospitalized patients: analysis of USA hospitals |
| |
Eur JGastroenterolHepatol. 2024Jul1;36(7):929940. doi:10.1097/MEG.0000000000002777.Epub 2024 Apr 23.
David Uihwan Lee 1, Ashton Harmacinski 1, Aneesh Bahadur 2, Ki Jung Lee 2, Hannah Chou 2, Mohammed Rifat Shaik 1, Harrison Chou 2, Gregory Hongyuan Fan 2, Jean Kwon 2, Reid Ponder 2, Kevin Chang 2, KeeSeok Lee 2, Zurabi Lominadze 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 154. | A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease |
| |
Hepatol Int. 2024 Jun 15. doi: 10.1007/s12072-024-10702-5. Online ahead of print.
Huai Zhang 1, Giovanni Targher 2, Christopher D Byrne 3, Seung Up Kim 4, Vincent Wai-Sun Wong 5, Luca Valenti 6 7, Myer Glickman 8, Jaime Ponce 9, Christos S Mantzoros 10, Javier Crespo 11, Henning Gronbaek 12, Wah Yang 13, Mohammed Eslam 14, Robert J Wong 15, Mariana Verdelho Machado 16, Ming-Lung Yu 17 18, Omar M Ghanem 19, Takeshi Okanoue 20, Jun-Feng Liu 21, Yong-Ho Lee 22, Xiao-Yuan Xu 23, Qiuwei Pan 24, Meili Sui 25, Amedeo Lonardo 26, Yusuf Yilmaz 27, Li-Yong Zhu 28, Christophe Moreno 29, Luca Miele 30, Monica Lupsor-Platon 31, Lei Zhao 32, Teresa LeAnn LaMasters 33, Robert G Gish 34, Huijie Zhang 35, Marius Nedelcu 36, Wah Kheong Chan 37, Ming-Feng Xia 38, Fernando Bril 39, Jun-Ping Shi 40, Christian Datz 41, Stefano Romeo 42 43 44, Jian Sun 45, Dan Liu 46, Silvia Sookoian 47 48 49, Yi-Min Mao 50, Nahum Méndez-Sánchez 51, Xiao-Yan Wang 52, Nikolaos T Pyrsopoulos 53, Jian-Gao Fan 54, Yasser Fouad 55, Dan-Qin Sun 56 57, Cosimo Giannini 58, Jin Chai 59, Ze-Feng Xia 60, Dae Won Jun 61, Guo-Jing Li 62, Sombat Treeprasertsuk 63, Ying-Xu Li |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
| | | | | | | |
